The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
Open accessAbstract
Gene or protein expression data are usually represented by metric or at least ordinal variables. In order to translate a continuous variable into a clinical decision, it is necessary to determine a cutoff point and to stratify patients into two groups each requiring a different kind of treatment. Currently, there is no standard method or standard software for biomarker cutoff determination. Therefore, we developed Cutoff Finder, a bundle of optimization and visualization methods for cutoff determination that is accessible online. While one of the methods for cutoff optimization is based solely on the distribution of the marker under investigation, other methods optimize the correlation of the dichotomization with respect to an outcome or survival variable. We illustrate the functionality of Cutoff Finder by the analysis of the gene expression of estrogen receptor (ER) and progesterone receptor (PgR) in breast cancer tissues. This distribution of these important markers is analyzed and correlated with immunohistologically determined ER status and distant metastasis free survival. Cutoff Finder is expected to fill a relevant gap in the available biometric software repertoire and will enable faster optimization of new diagnostic biomarkers. The tool can be accessed at http://molpath.charite.de/cutoff.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
Györffy, B., Lanczky, A., Eklund, A. C., Denkert, C., Budczies, J., Li, Q., & Szallasi, Z. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0674-9 · Cited by 4,169
Self-citationCamp, R. L., Dolled-Filhart, M., & Rimm, D. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0713 · Cited by 3,744
Harvey, J. M., Clark, G. M., Osborne, C. K., & Allred, D. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1474 · Cited by 2,056
Remmele, W., & Stegner, H.-E. (1987) · PubMed · Cited by 1,976
Perkins, N. J., & Schisterman, E. F. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj063 · Cited by 1,759
Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
Altman, D. G., Lausen, B., Sauerbrei, W., & Schumacher, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.829 · Cited by 1,143
NCBI GEO: archive for functional genomics data sets--10 years on
Barrett, T., Troup, D. B., Wilhite, S. E., Ledoux, P., Evangelista, C., Kim, I. F., Tomashevsky, M., Marshall, K. A., Phillippy, K. H., Sherman, P. M., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1184 · Cited by 1,124
Reporting Recommendations for Tumor Marker Prognostic Studies
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.0454 · Cited by 779
Allred, D. C., Clark, G. M., Elledge, R., Fuqua, S. A. W., Brown, R. W., Chamness, G. C., Osborne, C. K., & McGuire, W. L. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.3.200 · Cited by 772
Filipits, M., Rudas, M., Jakesz, R., Dubsky, P., Fitzal, F., Singer, C. F., Dietze, O., Greil, R., Jelen, A., Sevelda, P., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0926 · Cited by 733
FlexMix: A General Framework for Finite Mixture Models and Latent Class Regression in R
Leisch, F. (2004) · Journal of Statistical Software · doi:10.18637/jss.v011.i08 · Cited by 677
Maximally Selected Rank Statistics
Lausen, B., & Schumacher, M. (1992) · Biometrics · doi:10.2307/2532740 · Cited by 643
Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials
Sparano, J. A., & Paik, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1068 · Cited by 617
Maximally Selected Chi Square Statistics
Miller, R., & Siegmund, D. (1982) · Biometrics · doi:10.2307/2529881 · Cited by 490
Mazumdar, M., & Glassman, J. R. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000115)19:1<113::aid-sim245>3.0.co;2-o · Cited by 367
Progesterone Receptors as a Prognostic Factor in Stage II Breast Cancer
Clark, G. M., McGuire, W. L., Hubay, C. A., Pearson, O. H., & Marshall, J. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312013092240 · Cited by 366
Bonetti, M., & Gelber, R. D. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001015)19:19<2595::aid-sim562>3.0.co;2-m · Cited by 202
Patterns of treatment effects in subsets of patients in clinical trials
Bonetti, M. (2004) · Biostatistics · doi:10.1093/biostatistics/5.3.465 · Cited by 182
Bunder, M. W. (1976) · Journal of Symbolic Logic · doi:10.1017/s0022481200051537 · Cited by 160
Faraggi, D., & Simon, R. M. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19961030)15:20<2203::aid-sim357>3.0.co;2-g · Cited by 150
Why do so many prognostic factors fail to pan out?
Hilsenbeck, S. G., Clark, G. M., & McGuire, W. L. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01840833 · Cited by 138
Müller, B. M., Kronenwett, R., Hennig, G., et al. (2011) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e3181e3630c · Cited by 90
von Minckwitz, G., Müller, B. M., Loibl, S., Budczies, J., Hanusch, C. A., Darb‐Esfahani, S., Hilfrich, J., Weiss, E., Huober, J., Blohmer, J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.9079 · Cited by 88
Self-citationBonetti, M., Zahrieh, D., Cole, B. F., & Gelber, R. D. (2009) · Statistics in Medicine · doi:10.1002/sim.3524 · Cited by 45
On Maximally Selected Chi-Square Statistics
Koziol, J. A. (1991) · Biometrics · doi:10.2307/2532406 · Cited by 44
Darb‐Esfahani, S., Wirtz, R. M., Sinn, B. V., Budczies, J., Noske, A., Weichert, W., Faggad, A., Scharff, S., Sehouli, J., Oskay-Özcelik, G., et al. (2009) · Endocrine Related Cancer · doi:10.1677/erc-08-0338 · Cited by 37
Self-citation(1950) · doi:10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3
Cited by
Lánczky, A., & Győrffy, B. (2021) · Journal of Medical Internet Research · doi:10.2196/27633 · Cited by 1,694
Self-citationComprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
Abeshouse, A., Adebamowo, C., Adebamowo, S. N., Akbani, R., Akeredolu, T., Ally, A., Anderson, M. L., Anur, P., Appelbaum, E. L., Armenia, J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.014 · Cited by 1,069
Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors
Sha, D., Jin, Z., Budczies, J., Kluck, K., Stenzinger, A., & Sinicrope, F. A. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0522 · Cited by 859
Self-citationCircular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma
Yu, J., Xu, Q.-G., Wang, Z.-G., Yang, Y., Zhang, L., Ma, J.-Z., Sun, S.-H., Yang, F., & Zhou, W.-P. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.012 · Cited by 765
Aguirre-Gamboa, R., Gomez-Rueda, H., Martínez-Ledesma, E., Martínez-Torteya, A., Chacolla-Huaringa, R., Rodriguez-Barrientos, A., Tamez-Peña, J. G., & Treviño, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074250 · Cited by 686
Metadata
- Authors
- Budczies, J., Klauschen, F., Sinn, B. V., Győrffy, B., Schmitt, W. D., Darb-Esfahani, S., & Denkert, C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-14
- Volume
- 7
- Issue
- 12
- Pages
- e51862
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1969096316
- Cited by
- 1,224
- References
- 29
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.